The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy

Proceedings of the Society for Experimental Biology and Medicine

Volumn 217, Issue 3, 1998, Pages 365-368

  Clarkson, Thomas B ^a   Anthony, Mary S ^a   Williams, J Koudy ^a   Honoré, Erika K ^a   Cline, J Mark ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; LIPID; LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; PHYTOESTROGEN; PROTEIN; SOYBEAN PROTEIN;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIET; FEMALE; GENITAL SYSTEM; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS; NONHUMAN; POSTMENOPAUSE; RISK FACTOR; SOYBEAN;

GLYCINE MAX; PRIMATES;

EID: 0031951611     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44246     Document Type: Article

References (44)

1. National Center for Health Statistics. Health, United States, 1990. DHHS Publ. No. (PHS) 92-1232. Hyattsville, MD: National Center for Health Statistics, 1990.
2. Avila MH, Walker AM, Jick H. Use of replacement estrogens and the risk of myocardial infarction. Epidemiology 1:128-133, 1990.
3. Bush TL, Barrett-Connor E, Cowan DL, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-Up Study. Circulation 75:1102-1109, 1987.
4. Henderson BE, Pike MC, Ross RK, Mack TM, Lobo RA. Reevaluating the role of progestogen therapy after the menopause. Fertil Steril 49 (Suppl):9S-12S, 1988.
5. Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 94:620-635, 1987.
6. Petitti DB, Perlman JA, Sidney S. Postmenopausal estrogen use and heart disease (letter). N Engl J Med 315:131-132, 1986.
7. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 313:1044-1049, 1985.
8. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prevent Med 20:47-63, 1991.
9. Bush TL, Cowan LD, Barrett-Connor E, Criqui MH, Karon JM, Wallace RB, Tyroler A, Rifkind BM. Estrogen use and all-cause mortality: Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA 249:903-906, 1983.
10. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M, for the ARIC Investigators. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328:1069-1075, 1993.
11. Standeven M, Criqui MH, Klauber MR, Gabriel S, Barrett-Connor E. Correlates of change in postmenopausal estrogen use in a population-based study. Am J Epidemiol 124:268-274, 1986.
12. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of noncontraceptive hormone users. Prevent Med 17:403-411, 1988.
13. Hemminski E, Brambilla DJ, McKinlay SM, Posner JG. Use of estrogens among middle-aged Massachusetts women. Ann Pharmacother 25:418-422, 1991.
14. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 137:1125-1135, 1993.
15. Ravnikar VA. Compliance with hormone therapy. Am J Obstet Gynecol 156:1332, 1987.
16. Ravnikar VA. Compliance with hormone replacement therapy: Are women receiving the full impact of hormone replacement therapy's preventive health benefits? Women's Health Issues 2:75-82, 1992.
17. Meeker DR, Kesten HD. Effect of high protein diets on experimental atherosclerosis of rabbits. Arch Pathol 31:147-162, 1941.
18. Balogun EA, Balogun OO, Odutuga AA. Arginine:lysine ratio as a contributory factor to the hypocholesterolemic effect of plant protein sources. IRCS J Med Sci 10:643-644, 1982.
19. Huff MW, Carroll KK. Effects of dietary protein and amino acid mixtures on plasma cholesterol levels in rabbits. J Nutr 110:1676-1685, 1980.
20. Huff MW, Hamilton RMG, Carroll KK. Plasma cholesterol levels in rabbits fed low-fat, cholesterol-free, semi-purified diets: Effects of dietary proteins, protein hydrolysates, and amino acid mixtures. Atherosclerosis 28:187-195, 1977.
21. Kritchevsky D. Vegetable protein and atherosclerosis. J Am Oil Chem Soc 56:130-140, 1979.
22. Kritchevsky D, Tepper SA, Czarnecki S, Klurfeld DM. Atherogenicity of animal and vegetable protein: Influence of the lysine to arginine ratio. Atherosclerosis 47:429-431, 1982.
23. Nagata Y, Ishiwaki N, Sugano M. Studies on the mechanism of anti-hypercholesterolemic action of soy protein and soy protein-type amino acid mixtures in relation to the casein counterparts in rats. J Nutr 112:1614-1625, 1982.
24. Anthony MS, Clarkson TB, Hughes CL Jr., Morgan TM, Burke GL. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126:43-50, 1996.
25. Adlercreutz H. Western diet and Western diseases: Some hormonal and biochemical mechanisms and associations. Scand J Lab Clin Invest 50(Suppl 201):3-23, 1990.
26. Clarkson TB, Anthony MS, Hughes CL Jr. Estrogenic soybean isoflavones and chronic disease: Risks and benefits. Trends Endocrinol Metab 6:11-16, 1995.
27. Coward L, Barnes NC, Setchell KDR, Barnes S. Genistein, daidzein, and their β-glycoside conjugates: Antitumor isoflavones in soybean foods from American and Asian diets. J Agr Food Chem 41:1961-1967, 1993.
28. Adlercreutz H, Hämäläinen E, Gorbach S, Goldin B. Dietary phytooestrogens and the menopause in Japan (letter). Lancet 339:1233, 1992.
29. Barnes S, Peterson G, Grubbs C, Setchell K. Potential role of dietary isoflavones in the prevention of cancer. In: Jacobs MM, Ed. Diet and Cancer: Markers, Prevention, and Treatment. New York: Plenum Press, pp 135-147, 1994.
30. Knight DC, Eden JA. Phytoestrogens: A short review. Maturitas 22:167-175, 1995.
31. Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KDR, Weinberg CR, Haney AF, Wilcox AJ, McLachlan JA. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 80:1685-1690, 1995.
32. Cline JM, Soderqvist G, von Schoultz E, Skoog L, von Schoultz B. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am J Obstet Gynecol 174:93-100, 1996.
33. Bennets HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pasture in Western Australia. Austr Vet J 22:2-12, 1946.
34. Bradbury RB, White DE. The chemistry of subterranean clover. Part I. Isolation of formononetin and genistein. J Chem Soc 30:3447-3449, 1951.
35. Cheng E, Story CD, Yoder L, Hale WH, Burroughs W. Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal. Science 118:164-165, 1953.
36. Bickoff EM, Livingston AL, Hendrickson AP, Booth AN. Relative potencies of several estrogen-like compounds found in forages. J Agr Food Chem 41:1961-1967, 1993.
37. Setchell KDR, Gosselin SJ, Welsh MB, Johnston JO, Balistreri WF, Kramer LW, Dresser BL, Tarr MJ. Dietary estrogens: A probable cause of infertility and liver disease in captive cheetahs. Gastroenterology 93:225-233, 1987.
38. Wei H, Wei L, Frenkel K, Bowen R, Barnes S. Inhibition of tumor promoter induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20:1-12, 1993.
39. Fujio Y, Yamada F, Takahashi K, Shibata N. Responses of smooth muscle cells to platelet-derived growth factor are inhibited by herbimycin - a tyrosine kinase inhibitor. Biochem Biophys Res Commun 195:79-83, 1993.
40. Cline JM, Paschold JC, Anthony MS, Obasanjo IO, Adams MR. Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril 65:1031-1035, 1996.
41. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687, 1990.
42. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 20:452-457, 1992.
43. Williams JK, Honoré EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 24:1757-1761, 1994.
44. Honoré EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones in atherosclerotic female macaques. Fertil Steril 67:148-154, 1997.